Kuros Biosciences Ltd (SWX:KURN) - Share price


Stock Report

Kuros Biosciences Ltd KURN

Last Price
CHF1.90

Day Change
0.00|0.00%

As of 11/08/2022
17:00:18 CEST | CHF
Minimum 15 Minutes Delay.

Last Close1.90
Day Range1.83 - 1.90
Mkt Cap62.31Mil
52-Wk Range1.66 - 2.63
Yield %-
ISINCH0325814116
Volume992
P/E-
P/S4.51
P/CF-11.43

Share Price

Financials
201920202021
More ...
Income Statement
Revenue2.564.0413.82
Operating Income-11.39-11.68-8.77
Net Income-11.25-11.52-7.54
Basic EPS-0.65-0.47-0.23
Avg. Diluted Shares Outstanding172433
Balance Sheet
Current Assets23.2933.9732.89
Non Current Assets64.5660.4058.44
Total Assets87.8594.3691.34
Current Liabilities3.643.8811.29
Total Liabilities---
Total Equity77.8684.6076.98
Cash Flow
Operating Cash Flow-10.85-9.24-5.45
Capital Expenditure-0.12-0.22-0.37
Free Cash Flow-10.97-9.46-5.83

In millions, except "Basic EPS". Currency is CHF.

Company Profile

Kuros Biosciences Ltd is a biotechnology company that focuses on the discovery, development and prospective commercialization of a new class of bio-pharmaceutical products for use in the treatment and prevention of chronic diseases. The company is also developing a family of bone healing products to address indications in trauma, and spine as well as sealants which provides reliable closure of tissue membranes to ensure functional integrity after surgery or trauma. The pipeline products of the company are Synthetic Orthobiologics, Fibrin Orthobiologics, and Sealants. The majority of the company's revenue comes from the United States.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

58
Key Stats
More ...
Price/Earning TTM-8.26
Price/Book0.81
Price/Sales TTM4.51
Rev Growth (3 year avg)168.34
EPS Growth (3 year avg)-
Operating Margin % TTM-63.46
Net Margin % TTM-54.59
ROE TTM-9.33
Debt/Equity0.02
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.